DexCom (NASDAQ:DXCM – Free Report) had its price objective upped by Morgan Stanley from $101.00 to $122.00 in a report published on Monday morning, Benzinga reports. They currently have an equal weight rating on the medical device company’s stock. DXCM has been the topic of several other reports. Leerink Partnrs reaffirmed an outperform rating on […]
DexCom (NASDAQ:DXCM – Free Report) had its price objective raised by Morgan Stanley from $101.00 to $122.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have an equal weight rating on the medical device company’s stock. Several other research analysts have also recently weighed in on the stock. Leerink […]
Frontier Capital Management Co. LLC lessened its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 705,970 shares of the medical device company’s stock after selling 23,682 shares during the […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) Director Steven Robert Pacelli sold 411 shares of the business’s stock in a transaction dated Friday, November 24th. The shares were sold at an average price of $110.80, for a total transaction of $45,538.80. Following the completion of the transaction, the director now directly owns 124,775 shares of […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) Director Steven Robert Pacelli sold 411 shares of the business’s stock in a transaction that occurred on Friday, November 24th. The shares were sold at an average price of $110.80, for a total value of $45,538.80. Following the transaction, the director now owns 124,775 shares of the company’s […]